Science

New study examines how diabetes and weight-loss drugs affect employment and working hours

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 03/11/2026, 12:25:24 UTC.

Briefings

A new study from NYU Abu Dhabi using Danish population data reveals that diabetes treatment increases employment likelihood, whereas weight-loss medications extend working hours for employed individuals. The research suggests these drug effects influence income tax revenue and public health care spending, with implications for economic policy and healthcare budgeting.

Key points

• Diabetes treatment in Denmark increased the likelihood of employment among individuals with the condition.
• Weight-loss medications in Denmark resulted in longer working hours for people who were already employed.

Context

This research analyzes how specific pharmaceutical treatments for chronic conditions impact labor market participation and duration, using comprehensive population-level data from Denmark to inform economic and fiscal planning.

Limitations

Data covers only the Danish population, limiting generalizability to other regions. Findings are observational and do not establish causality; other factors could influence employment outcomes. Income tax and public health spending implications are projections based on observed trends rather than confirmed financial outcomes.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 04/11/2026, 00:10:24 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiadi6vfb5qt26nfs65sh2itum4xrnejagabunixty6xa52vvzs7ka